Back to Search
BRANDON SHEAHAN, D.M.D.
D.M.D.
Dentist
NPI: 1780024547Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
D-4489(ID)
Research & Publications (20)
Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.
PMID 19403754·J Gen Virol·2009
7-preclinical
The 5' untranslated region as a pathogenicity determinant of Semliki Forest virus in mice.
PMID 18264748·Virus Genes·2008
7-preclinical
Therapeutic and prophylactic applications of alphavirus vectors.
PMID 19000329·Expert Rev Mol Med·2008
6-review
Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.
PMID 17167497·Gene Ther·2007
7-preclinical
Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.
PMID 17905485·Vaccine·2007
7-preclinical
Inhibition of murine K-BALB and CT26 tumour growth using a Semliki Forest virus vector with enhanced expression of IL-18.
PMID 16969484·Oncol Rep·2006
7-preclinical
The effect of infection of hatched blastocyst bovine embryos with border disease and bovine viral diarrhea viruses.
PMID 16771222·Southeast Asian J Trop Med Public Health·2006
7-preclinical
Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.
PMID 16528043·J Gen Virol·2006
7-preclinical
Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.
PMID 15372069·Gene Ther·2005
7-preclinical
The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo.
PMID 16211309·Oncol Rep·2005
7-preclinical
Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12.
PMID 15944731·Gene Ther·2005
7-preclinical
Alphaviruses and their derived vectors as anti-tumor agents.
PMID 15578917·Curr Cancer Drug Targets·2004
6-review
Calcospherite-like bodies and caseous necrosis in tracheal mucus from a dog with tuberculosis.
PMID 15334354·Vet Clin Pathol·2004
5-case
Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.
PMID 14664790·Mol Ther·2003
7-preclinical
Role of interferon-gamma and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection.
PMID 14636162·Neuropathol Appl Neurobiol·2003
7-preclinical
Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection.
PMID 12909414·Vet Immunol Immunopathol·2003
7-preclinical
Avirulent Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity.
PMID 11960636·J Neuroimmunol·2002
7-preclinical
Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector.
PMID 11745446·Int J Cancer·2001
7-preclinical
Progressive encephalomyelopathy and cerebellar degeneration in 10 captive-bred cheetahs.
PMID 11488342·Vet Rec·2001
7-preclinical
A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model.
PMID 11427261·Vaccine·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6 W MAIN ST
EAST HELENA, MT 59635 - Phone
- (406) 227-5886
Quick Facts
- NPI
- 1780024547
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile